These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24927708)

  • 1. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
    Mato Abad V; Quirós A; García-Álvarez R; Loureiro JP; Alvarez-Linera J; Frank A; Hernández-Tamames JA
    J Alzheimers Dis; 2014; 42(3):801-11. PubMed ID: 24927708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
    Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
    J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate statistical analysis of diffusion imaging parameters using partial least squares: Application to white matter variations in Alzheimer's disease.
    Konukoglu E; Coutu JP; Salat DH; Fischl B;
    Neuroimage; 2016 Jul; 134():573-586. PubMed ID: 27103138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometric network differences in ageing versus Alzheimer's disease dementia.
    Pichet Binette A; Gonneaud J; Vogel JW; La Joie R; Rosa-Neto P; Collins DL; Poirier J; Breitner JCS; Villeneuve S; Vachon-Presseau E; ;
    Brain; 2020 Feb; 143(2):635-649. PubMed ID: 32040564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
    Modrego PJ; Fayed N; Pina MA
    Am J Psychiatry; 2005 Apr; 162(4):667-75. PubMed ID: 15800137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease.
    Acosta O; Fripp J; Doré V; Bourgeat P; Favreau JM; Chételat G; Rueda A; Villemagne VL; Szoeke C; Ames D; Ellis KA; Martins RN; Masters CL; Rowe CC; Bonner E; Gris F; Xiao D; Raniga P; Barra V; Salvado O
    J Neurosci Methods; 2012 Mar; 205(1):96-109. PubMed ID: 22226742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2010; 30(1):71-7. PubMed ID: 20689286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour.
    Poloni G; Bastianello S; Vultaggio A; Pozzi S; Maccabelli G; Germani G; Chiarati P; Pichiecchio A
    Funct Neurol; 2008; 23(4):207-13. PubMed ID: 19331784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
    Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z
    Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
    J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
    Watanabe T; Shiino A; Akiguchi I
    Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.